A. Friedman

发表

Metastatic Melanoma to the Spine Demographics, Risk Factors, and Prognosis in 114 Patients

H. Seigler, W. Richardson, J. Sampson, 1995, Spine.

Dosimetry of 1311-Labeled81C6 Monoclonal Antibody Administered into Surgically Created Resection Cavities in Patients with Malignant Brain Tumors

D. Bigner, H. Friedman, M. Zalutsky, 2006 .

Neurosurgery residency and fellowship education in the United States: 2 decades of system development by the One Neurosurgery Summit organizations.

N. Barbaro, N. Selden, A. Day, 2021, Journal of neurosurgery.

Reply from the author:

M. Alberts, A. Friedman, 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Isolated Deep Ear Canal Pain: Possible Role of Auricular Branch of Vagus Nerve-Case Illustrations with Cadaveric Correlation.

R. Tubbs, A. Zomorodi, W. Liedtke, 2016, World neurosurgery.

Three-dimensional Computed Tomographic Cranial Base Measurements for Improvement of Surgical Approaches to the Petrous Carotid Artery and Apex Regions

A. Friedman, K. Bulsara, A. Villavicencio, 2001, Neurosurgery.

Cerebellopontine angle meningiomas: postoperative outcomes in a modern cohort.

O. Adogwa, R. Babu, T. Fukushima, 2013, Neurosurgical focus.

Treatment of Neoplastic Meningitis with Intrathecal Temozolomide 1

R. McLendon, D. Bigner, H. Friedman, 2000 .

A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma

A. Friedman, H. Friedman, D. Reardon, 2011, Journal of Neuro-Oncology.

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

A. Friedman, H. Friedman, D. Reardon, 2005, Cancer.

Molecular markers of prognosis in astrocytic tumors

R. McLendon, D. Bigner, S. Bigner, 2002, Cancer.

Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis

R. McLendon, A. Friedman, J. Provenzale, 2000, Acta Neuropathologica.

Loss of heterozygosity for 10q loci in human gliomas

A. Friedman, B. A. Rasheed, D. Bigner, 1992, Genes, chromosomes & cancer.

Long-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution Experience

H. Friedman, A. Zomorodi, J. Kirkpatrick, 2021, Advances in radiation oncology.

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

R. McLendon, Hai Yan, D. Bigner, 2018, Nature Communications.

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma

R. McLendon, H. Friedman, D. Reardon, 2012, Journal of Neuro-Oncology.

Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

R. McLendon, H. Friedman, D. Reardon, 2011, Cancer.

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

R. McLendon, J. Provenzale, H. Friedman, 2007, Journal of Neuro-Oncology.

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma

R. McLendon, A. Friedman, J. Provenzale, 2005, Cancer.

Bilateral Transpedicular Decompression and Harrington Rod Stabilization in the Management of Severe Thoracolumbar Burst Fractures

R. Fitch, W. Hardaker, W. A. Cook, 1992, Spine.

An Injectable and In Situ-Gelling Biopolymer for Sustained Drug Release Following Perineural Administration

A. Friedman, L. Setton, M. Shamji, 2008, Spine.

Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines

Peter Fecci, John Sampson, M. Shamji, 2008, Neurosurgical Review.

Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma

R. McLendon, A. Friedman, D. Bigner, 2010, Journal of Neuro-Oncology.

Survival analysis of presumptive prognostic markers among oligodendrogliomas

R. McLendon, A. Friedman, B. A. Rasheed, 2005, Cancer.

Less invasive transjugular approach with Fallopian bridge technique for facial nerve protection and hearing preservation in surgery of glomus jugulare tumors

A. Zomorodi, T. Fukushima, Y. Nonaka, 2013, Neurosurgical Review.

Indication for a skull base approach in microvascular decompression for hemifacial spasm

T. Fukushima, Takuro Inoue, S. Shitara, 2022, Acta Neurochirurgica.

Topotecan treatment of adults with primary malignant glioma

R. McLendon, A. Friedman, S. Arbuck, 1999, Cancer.

Neuronal migration disorders: Positron emission tomography correlations

W. J. Oakes, A. Friedman, T. Montine, 1994, Annals of neurology.

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

D. Bigner, H. Friedman, D. Reardon, 2009, Cancer.

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

R. McLendon, A. Friedman, H. Friedman, 2011, Journal of Neuro-Oncology.

Cryptococcal meningitis in patients with glioma: a report of two cases

A. Friedman, J. Sampson, J. Vredenburgh, 2008, Journal of Neuro-Oncology.

Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy

R. McLendon, A. Friedman, H. Friedman, 2009, Journal of Neuro-Oncology.

Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma

W. Kraus, H. Friedman, D. Reardon, 2010, Cancer.

Clinical Studies in Non-chromosome 4-Linked Facioscapulohumeral Muscular Dystrophy

J. Gilbert, M. Pericak-Vance, E. Rampersaud, 2001, Journal of clinical neuromuscular disease.

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma

R. McLendon, H. Friedman, D. Reardon, 2009, Journal of Neuro-Oncology.

Oncolytic polio virotherapy of cancer

D. Bigner, H. Friedman, D. Tyler, 2014, Cancer.

Second Case of Tumors Associated With Heterozygous NTHL1 Variant

Trenton Reinicke, Danyon Anderson, A. Friedman, 2022, Cureus.

Inhibitory simple partial (non-convulsive) status epilepticus after intracranial surgery

C. Armon, R. Radtke, A. Friedman, 2000, Journal of neurology, neurosurgery, and psychiatry.

Predictors of Outcome of Epilepsy Surgery: Multivariate Analysis with Validation

A. Friedman, C. Armon, R. Radtke, 1996, Epilepsia.

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.

Kendra L. Congdon, R. McLendon, D. Bigner, 2018, Cancer research.

CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA

R. McLendon, D. Bigner, E. Thompson, 2021, Neuro-Oncology.

fMRI activation mapping as a percentage of local excitation: Consistent presurgical motor maps without threshold adjustment

James T Voyvodic, Allan H Friedman, Jeffrey R Petrella, 2009, Journal of magnetic resonance imaging : JMRI.

Long term response in a patient with neoplastic meningitis secondary to melanoma treated with 131I‐radiolabeled antichondroitin proteoglycan sulfate Mel‐14 F(ab′)2

D. Bigner, J. Provenzale, H. Friedman, 2001, Cancer.

Seizure outcome after temporal lobectomy for temporal lobe epilepsy

J. McNamara, E. Mascha, N. Foldvary, 2000, Neurology.

Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas

A. Friedman, J. Cairncross, P. Burger, 1991, Neurology.

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

A. Friedman, H. Seigler, J. Sampson, 1998, Journal of neurosurgery.

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.

A. Friedman, P. Burger, K. Black, 1991, Journal of neurosurgery.

Castleman's disease confined to the leptomeninges.

R. McLendon, A. Friedman, T. Cummings, 2000, Annals of clinical and laboratory science.

Treatment of radiation‐induced nervous system injury with heparin and warfarin

A. Friedman, P. Burger, S. Schold, 1994, Neurology.

Dorsal root entry zone lesions for the treatment of post-herpetic neuralgia.

A. Friedman, B. Nashold, J. Ovelmen-Levitt, 1984, Journal of neurosurgery.

PTEN gene mutations are seen in high-grade but not in low-grade gliomas.

R. McLendon, A. Friedman, D. Bigner, 1997, Cancer research.

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.

A. Friedman, D. Bigner, G. Dranoff, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

R. McLendon, A. Friedman, D. Bigner, 2009, British Journal of Cancer.

A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.

R. Coleman, R. McLendon, A. Friedman, 2008, Neuro-oncology.

Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.

R. Coleman, R. McLendon, A. Friedman, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.

R. Coleman, R. McLendon, A. Friedman, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

R. Coleman, R. McLendon, A. Friedman, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MR and positron emission tomography in the diagnosis of surgically correctable temporal lobe epilepsy.

J M Hoffman, J. Hoffman, B. Crain, 1994, AJNR. American journal of neuroradiology.

Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification.

A. Friedman, S. Bigner, H. Friedman, 2000, Neuro-oncology.

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

R. McLendon, A. Friedman, D. Bigner, 1999, The American journal of pathology.

Comparison of [125I]HIPDm and [125I]iodoantipyrine in quantifying regional cerebral blood flow in rats.

R. Coleman, B. Drayer, E. Fram, 1988, Stroke.

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Susan M. Chang, A. Friedman, J. Olson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia.

R. Coleman, A. Friedman, J. Hoffman, 1993, AJNR. American journal of neuroradiology.

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

R. McLendon, A. Friedman, D. Bigner, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The genetic landscape of anaplastic astrocytoma

R. McLendon, A. Friedman, Siân Jones, 2013, Oncotarget.

Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients

A. Friedman, E. Lipp, H. Friedman, 2012, British Journal of Cancer.

Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.

R. Coleman, R. McLendon, A. Friedman, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.

R. McLendon, A. Friedman, D. Bigner, 1997, Cancer research.

Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy.

R. Coleman, D. DeLong, R. McLendon, 2000, International journal of radiation oncology, biology, physics.

Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.

R. McLendon, A. Friedman, I. Pastan, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Temporal lobe hypometabolism on PET

R. Coleman, A. Friedman, J. Hoffman, 1993, Neurology.

Ganglioglioma: a clinical study with long-term follow-up.

A. Friedman, S. Zeidman, E. Rossitch, 1991, Surgical neurology.

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

R. McLendon, A. Friedman, D. Bigner, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke.

A. Friedman, H. Friedman, S. Lovell, 1998, Medical and pediatric oncology.

Alterations of the TP53 gene in human gliomas.

R. McLendon, A. Friedman, D. Bigner, 1994, Cancer research.

Potential Additional Indicators for Pacemaker Requirement in Isolated Congenital Atrioventricular Block

M. I. Cohen, J. Crosson, J. Brenner, 2006, Pediatric Cardiology.

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.

R. McLendon, A. Friedman, M. Dolan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dorsal root entry zone lesions for the treatment of brachial plexus avulsion injuries: a follow-up study.

A. Friedman, B. Nashold, A. Friedman, 1988, Neurosurgery.

In vivo quantitation of regional cerebral blood flow in glioma and cerebral infarction: validation of the HIPDm-SPECT method.

R. Jaszczak, K. Greer, B. Drayer, 1983, AJNR. American journal of neuroradiology.

Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas.

R. McLendon, A. Friedman, J. Provenzale, 2001, Neuro-oncology.

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

M M Haglund, T Kerby, R. McLendon, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

Mitchel S Berger, Allan H Friedman, James M Provenzale, 2008, Neuro-oncology.

Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.

R. McLendon, E. Thompson, E. Lipp, 2023, The Lancet. Child & adolescent health.

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

R. McLendon, D. Bigner, H. Friedman, 2009, British Journal of Cancer.

Chemotherapy for adults with malignant glioma.

A. Friedman, H. Friedman, I. Cokgor, 1999, Cancer investigation.

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.

R. McLendon, A. Friedman, M. Dolan, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

D. Bigner, H. Friedman, D. Reardon, 2009, Cancer.